Brought to you by 
Gilead, Kite buy Cell Design Labs
03 Sep 2020
Executive Summary
Just four months after thrusting itself into the cell therapy space through the $11.9bn acquisition of Kite Pharma Inc., Gilead Sciences Inc. is acquiring privately held Cell Design Labs Inc., another player in the engineered cellular therapeutics market.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Gene Therapy, Cell Therapy
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Includes Earnout
- Intra-Biotech Deal
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Gilead, Kite buy Cell Design Labs
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice